Results 91 to 100 of about 2,292,561 (368)
Is neuroscience facing up to statistical power? [PDF]
arXiv, 2017 It has been demonstrated that the statistical power of many neuroscience studies is very low, so that the results are unlikely to be robustly reproducible. How are neuroscientists and the journals in which they publish responding to this problem? Here I review the sample size justifications provided for all 15 papers published in one recent issue of ...
arxiv
Function-Theoretic Explanation and the Search for Neural Mechanisms [PDF]
, 2017 A common kind of explanation in cognitive neuroscience might be called functiontheoretic: with some target cognitive capacity in view, the theorist hypothesizes that the system computes a well-defined function (in the mathematical ...
Egan, Frances
core +2 more sources
Early Language Impairment as an Integral Part of the Cognitive Phenotype in Huntington's Disease
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Huntington's disease (HD) speech/language disorders have typically been attributed to motor and executive impairment due to striatal dysfunction. In‐depth study of linguistic skills and the role of extrastriatal structures in HD is scarce.
Arnau Puig‐Davi +13 more
wiley +1 more source
The Roles of Supervised Machine Learning in Systems Neuroscience [PDF]
arXiv, 2018 Over the last several years, the use of machine learning (ML) in neuroscience has been rapidly increasing. Here, we review ML's contributions, both realized and potential, across several areas of systems neuroscience. We describe four primary roles of ML within neuroscience: 1) creating solutions to engineering problems, 2) identifying predictive ...
arxiv
Neuroscience and the Model Penal Code\u27s Mens Rea Categories [PDF]
, 2021 This Essay addresses recent research and commentary regarding the potential contributions of cognitive neuroscience to law. For the first time, cognitive neuroscience methods have been brought to bear on the Model Penal Code’s (MPC’s) culpable–mental ...
Kuersten, Andreas, Medaglia, John D.
core +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT C‐truncating variants in the charged multivesicular body protein 2B (CHMP2B) gene are a rare cause of frontotemporal lobar degeneration (FTLD), previously identified only in Denmark, Belgium, and China. We report a novel CHMP2B splice‐site variant (c.35‐1G>A) associated with familial FTLD in Spain. The cases were two monozygotic male twins who
Sara Rubio‐Guerra +17 more
wiley +1 more source
Critical appraisal on mitochondrial dysfunction in Alzheimer’s disease
AGING MEDICINE, Volume 5, Issue 4, Page 272-280, December 2022., 2022 Amyloid plaques deposit on neurons in case of Alzheimer's Disease. Mitochondria play a vital role in pathogenesis of Alzheimer's Disease. Mitochondrial dysfunction can lead to formation of mPTP, alteration of complexes 1,3 and 4, deficits in bioenergetics with impaired mitochondrial biogenesis. Abstract It is widely recognized that Alzheimer's disease (
Faizan Ahmad, Punya Sachdeva
wiley +1 more source
What can topology tell us about the neural code? [PDF]
Bulletin of the AMS, vol. 54, no. 1, pp. 63-78, January 2017, 2016 Neuroscience is undergoing a period of rapid experimental progress and expansion. New mathematical tools, previously unknown in the neuroscience community, are now being used to tackle fundamental questions and analyze emerging data sets. Consistent with this trend, the last decade has seen an uptick in the use of topological ideas and methods in ...
arxiv
Diagnostic Challenge in Frontal Variant Alzheimer's Disease With Low Amyloid‐β PET Retention
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Diagnosing frontal variant Alzheimer's disease (fvAD) is difficult and could be even more difficult when amyloid‐beta (Aβ) PET retention is low. A 63‐year‐old woman presenting with a 3‐year history of apathy and memory impairment showed executive dysfunction, memory impairment, and severe bilateral frontotemporal atrophy on MRI.
Ryosuke Shimasaki +5 more
wiley +1 more source
A pilot randomized controlled trial of WeiNaoKang (SaiLuoTong) in treating vascular dementia
AGING MEDICINE, Volume 5, Issue 4, Page 246-256, December 2022., 2022 A 16‐week randomized double‐blind, placebo‐controlled trial for vascular dementia was carried out with WeiNaoKang (or SaiLuoTong). There were significant differences in improvement in cognitive function and activities of daily living, favouring the treatment group.
Junguang Liu +6 more
wiley +1 more source